Industry Briefs: Feb. 27, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: Feb. 27, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Almac has acquired two pieces of encapsulation equipment for its North American headquarters in Souderton, Pennsylvania. Read More

Angiochem and GlaxoSmithKline have formed a collaboration to discover, develop, and commercialize treatments for lysosomal storage diseases. Read More

Auxilium Pharmaceuticals and Actelion Pharmaceuticals have formed a collaboration agreement for Xiaflex (collagenase clostridium histolyticum). Read More

BASF has launched a white biotechnology and microbiology research laboratory at its Tarrytown, New York, facility. Read More

Boehringer Ingelheim and Xencor have formed a collaboration agreement for the development, manufacture, and supply of biosuperior monoclonal antibodies. Read More

EMD Millipore has partnered with Charles River Laboratories for viral-clearance studies. Read More

In other news, EMD Millipore has opened its first laboratory water-production site in China. Read More

Haupt Pharma and the Fraunhofer Institute optimize Haupt’s supply-chain capabilities. Read More

Hospira has joined the Generic Pharmaceutical Association (GPhA). Read More

Penn Pharma plans a £14-million ($22.2 million) investment in its South Wales, United Kingdom, facility to increase its global supply and its high-containment manufacturing capabilities. Read More

Pfizer has acquired Alacer, a vitamin supplements company. Read More

Roche has extended its tender offer for Illumina. Read More

Sol-Gel has signed a $24.7-million agreement with an undisclosed pharmaceutical company for the development and commercialization in the United States and Canada of a dermatologic drug. Read More

People News

Amarillo Biosciences has appointed Stephen Chen as chairman and CEO. Joseph Cummins will remain as president and chief operating officer. Read More

DPT Laboratories has named Kuljit Bhatia as vice-president of R&D. Read More

Johnson & Johnson’s (J&J) board of directors has named Alex Gorsky to succeed Bill Weldon as CEO, effective Apr. 26, 2012. Gorsky was also nominated for election to the board of directors at J&J’s annual meeting of shareholders. Read More

Mylan North America President Tony Mauro has been elected chairman of GPhA. Read More

OSO BioPharmaceuticals has appointed Marian Meyer as director of laboratories. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here